DE69007571D1 - Peptidfragmente von HIV. - Google Patents

Peptidfragmente von HIV.

Info

Publication number
DE69007571D1
DE69007571D1 DE90308662T DE69007571T DE69007571D1 DE 69007571 D1 DE69007571 D1 DE 69007571D1 DE 90308662 T DE90308662 T DE 90308662T DE 69007571 T DE69007571 T DE 69007571T DE 69007571 D1 DE69007571 D1 DE 69007571D1
Authority
DE
Germany
Prior art keywords
proline
isoleucine
peptide
fragment
peptide fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE90308662T
Other languages
English (en)
Other versions
DE69007571T2 (de
Inventor
Andrew James Mcmichael
Douglas Fraser Nixon
Alain Robert Michael Townsend
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Biomedical Inc
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43806939&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69007571(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of DE69007571D1 publication Critical patent/DE69007571D1/de
Application granted granted Critical
Publication of DE69007571T2 publication Critical patent/DE69007571T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69007571T 1989-08-09 1990-08-07 Peptidfragmente von HIV. Revoked DE69007571T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898918200A GB8918200D0 (en) 1989-08-09 1989-08-09 The peptide fragments of hiv

Publications (2)

Publication Number Publication Date
DE69007571D1 true DE69007571D1 (de) 1994-04-28
DE69007571T2 DE69007571T2 (de) 1994-09-08

Family

ID=43806939

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69007571T Revoked DE69007571T2 (de) 1989-08-09 1990-08-07 Peptidfragmente von HIV.

Country Status (12)

Country Link
US (1) US5700635A (de)
EP (1) EP0412766B1 (de)
JP (1) JPH04507100A (de)
AT (1) ATE103294T1 (de)
CA (1) CA2064691A1 (de)
DE (1) DE69007571T2 (de)
DK (1) DK0412766T3 (de)
ES (1) ES2054256T3 (de)
GB (2) GB8918200D0 (de)
HK (1) HK141494A (de)
SG (1) SG130094G (de)
WO (1) WO1991001996A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
DE346022T1 (de) * 1988-06-10 1990-05-23 Medical Research Council, London Peptidfragmente von hiv.
EP0510054A1 (de) * 1990-01-05 1992-10-28 United Biomedical, Inc. Hiv-1-core-proteinfragmente
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
KR100235849B1 (ko) * 1993-10-19 1999-12-15 에가시라 구니오 HIV에 대한 면역응답을 유도할 수 있는 펩티드 및 그 펩티드를 함유하는 항 AIDS 예방, 치료제(Peptides Capable of Inducing Immune Response to HIV and Anti-AIDS Agent for Preventing and Curing AIDS)
GB9426153D0 (en) * 1994-12-23 1995-02-22 Medical Res Council Improvements in or relating to vaccines
CA2392877C (en) * 1999-12-23 2011-11-15 Tomas Hanke Improvements in or relating to immune responses to hiv
CU23235A1 (es) * 2001-02-28 2007-09-26 Ct Ingenieria Genetica Biotech POXVIRUS RECOMBINANTES PARA PROTEINAS QUIMéRICAS DEL VIRUS DE LA INMUNODEFICIENCIA HUMANA Y SU APLICACION EN LA TERAPéUTICA Y LA PREVENCION DEL SIDA
AU2009240507B2 (en) * 2008-04-24 2014-12-18 Ccl Label, Inc. Sheet having removable labels and related method
EP2620446A1 (de) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogene zur HIV-Impfung
WO2021094984A1 (en) 2019-11-14 2021-05-20 Aelix Therapeutics, S.L. Dosage regimens for vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62164696A (ja) * 1986-01-06 1987-07-21 エフ．ホフマン　―　ラ　ロシュ　アーゲー ＨＴＬＶ−３ｇａｇ遺伝子の発現
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
EP0330359A3 (de) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion

Also Published As

Publication number Publication date
WO1991001996A1 (en) 1991-02-21
GB2250994A (en) 1992-06-24
EP0412766A1 (de) 1991-02-13
SG130094G (en) 1995-01-13
JPH04507100A (ja) 1992-12-10
ES2054256T3 (es) 1994-08-01
GB8918200D0 (en) 1989-09-20
ATE103294T1 (de) 1994-04-15
DK0412766T3 (da) 1994-07-18
CA2064691A1 (en) 1991-02-10
DE69007571T2 (de) 1994-09-08
EP0412766B1 (de) 1994-03-23
GB9201468D0 (en) 1992-04-01
US5700635A (en) 1997-12-23
GB2250994B (en) 1993-08-25
HK141494A (en) 1994-12-23

Similar Documents

Publication Publication Date Title
GB2255093A (en) Hiv-1 core protein fragments
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
ATE127345T1 (de) Stressproteine und verwendungen dafür.
ATE188612T1 (de) Konjugate von schwach immunogenen antigenen und synthetischen peptidträgern und impfstoffe diese enthaltend
DE68925660D1 (de) Peptidfragmente von HIV
ATE103294T1 (de) Peptidfragmente von hiv.
DK0491628T3 (da) Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
ES2071038T3 (es) Peptidos asociados al hiv.
NZ224251A (en) Synthetic rhinovirus (hrv) peptides and vaccines
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
IL91609A0 (en) Allelic variants of plasmodium falciparum merozoite surface antigen
ES2061944T3 (es) Conjugado de peptido inmunologicamente activo ppd (nanp)n util como vacuna antimalaria.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: UNITED BIOMEDICAL INC., HAUPPAUGE, N.Y., US

8331 Complete revocation